EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M503. A total of 15 filers reported holding EYEGATE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $47,000 | -38.2% | 20,981 | 0.0% | 0.00% | – |
Q2 2021 | $76,000 | -41.5% | 20,981 | -20.0% | 0.00% | – |
Q1 2021 | $130,000 | +0.8% | 26,235 | 0.0% | 0.00% | – |
Q4 2020 | $129,000 | +25.2% | 26,235 | 0.0% | 0.00% | – |
Q3 2020 | $103,000 | -18.3% | 26,235 | 0.0% | 0.00% | – |
Q2 2020 | $126,000 | -7.4% | 26,235 | 0.0% | 0.00% | – |
Q1 2020 | $136,000 | -48.1% | 26,235 | 0.0% | 0.00% | – |
Q4 2019 | $262,000 | – | 26,235 | +62364.3% | 0.00% | – |
Q3 2019 | $0 | – | 42 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 3,346,601 | $12,182,000 | 0.22% |
Parkman Healthcare Partners LLC | 75,647 | $275,000 | 0.06% |
Sterling Financial Planning, Inc. | 1,171 | $4,000 | 0.00% |
Newbridge Financial Services Group, Inc. | 1,000 | $4,000 | 0.00% |
UBS Group AG | 399 | $1,000 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 27,061 | $99,000 | 0.00% |
OSAIC HOLDINGS, INC. | 468 | $2,000 | 0.00% |
US BANCORP \DE\ | 2,710 | $10,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 40 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |